Genetic Polymorphism of HLA-G 14-bp Insertion/Deletion in Pancreas Transplant Recipients and Its Association With Type 1 Diabetes Mellitus

Exp Clin Transplant. 2021 Feb;19(2):154-159. doi: 10.6002/ect.2018.0162. Epub 2019 Jan 31.

Abstract

Objectives: Human leukocyte antigen-G is an immuno-modulatory factor that affects acute allograft rejection and autoimmune diseases such as type 1 diabetes mellitus. In this study, possible associations between human leukocyte antigen-G 14-bp insertion/deletion polymorphism and acute pancreas rejection were investigated.

Materials and methods: Human leukocyte antigen-G genotyping was assessed in 102 Iranian pancreas transplant recipients (including 41 with acute rejection and 61 with nonacute rejection). Results were compared with 100 individuals in a normal control group.

Results: No significant differences in genotype frequencies of human leukocyte antigen-G 14-bp insertion / deletion were observed in recipients who had acute rejection episodes. On the other hand, the insertion / insertion genotype was a risk factor for susceptibility to type 1 diabetes mellitus (odds ratio = 3.82, 95% confidence interval, 1.37- 11.22; P = .005).

Conclusions: Our results provided evidence revealing that the human leukocyte antigen-G insertion / insertion genotype might be involved in the pathogenesis of type 1 diabetes mellitus.

MeSH terms

  • Diabetes Mellitus, Type 1* / diagnosis
  • Diabetes Mellitus, Type 1* / genetics
  • Genotype
  • Graft Rejection / genetics*
  • HLA-G Antigens* / genetics
  • Humans
  • INDEL Mutation*
  • Iran
  • Pancreas
  • Pancreas Transplantation*
  • Polymorphism, Genetic
  • Transplant Recipients

Substances

  • HLA-G Antigens